Search results for: Maria Lowe
Filter search results
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
1 December 2021
…evidence collection and in administering the agreement. However, there are also issues associated with the alternatives which for payers involve either lower prices or innovators providing additional evidence and for…
G7 Investments in New Antibiotics Would Pay Off – For Everyone
9 December 2022
…AMR death. We use USD (at average 2022 exchange rates) for consistency and err on the conservative side where relevant, e.g., using the lower end of a threshold range. Table…
Patrick Holmes
3 February 2023
…of therapeutic areas including hypertension, lipid lowering, arrhythmia, diabetes, erectile dysfunction, and allergies. Patrick then switched to a strategic planning role where he was responsible for evaluating new product opportunities…
Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges
6 February 2023
…affect poorer populations with a lower ability to pay. Despite numerous benefits – which are simultaneously ambitious, practical, and impactful – limitations and challenges remain. Questions include: How would drugs…
The US Inflation Reduction Act: What Do the Experts Think?
25 May 2023
…interesting insights were provided, and CMS were keen to emphasise the benefits to patients in terms of lower out-of-pocket spending. Research was presented in poster format estimating that over 8140,000…
Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment
11 July 2023
…and medicine research and development (R&D) is significantly lower in comparison to other diseases such as cancer. However, recent breakthroughs and growing R&D pipeline show that this area has high…
OHE Annual Lecture 2023 | The ECO-nomics of Health in a Shifting Climate: Fostering Well-being, Sustainable Livelihoods, and a Greener Future
13 September 2023, 6:00pm
…with over twenty-five years’ experience undertaking research particularly in lower-income countries, including six while living in Tanzania and Ghana. Her research addresses the design of policies and institutions to reduce…
NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
18 September 2023
…negative decision as leverage to negotiate a lower price. That being said, the future impact of NICE on the global Health Technology Assessment (HTA) landscape may change in the near…
Proposals for a Novel UK Antimicrobial Subscription Model: The Investor Perspective
2 November 2023
…or the assessment of eligibility and clinical value. The upper bands (£15m, £20m) are deemed sufficient to be effective as England’s proportion of a global pull incentive, but the lower…